Overview: Roflumilast is a selective phosphodiesterase-4 (PDE4) inhibitor approved for the treatment of chronic obstructive pulmonary disease (COPD) [89]. The gene discussed is PDE4A; the disease is chronic obstructive pulmonary disease.